Being honest about lupus symptoms and challenges helps us be proactive and stay committed to our health, writes columnist ...

Stuck in a monthslong lupus flare-up, columnist Marisa Zeppieri shares words of wisdom about self-worth, healing, and the ...

To help you learn a little bit more about what you should and shouldn’t be eating, we’ve put together a list of foods that you might want to avoid if you’re a lupus patient (source: healthline.com): ...

Brepocitinib, an investigational oral therapy, failed to show any benefits beyond a placebo in a Phase 2 clinical trial that tested it in adults with moderate to severely active systemic lupus ...

People often fail to acknowledge the type of grief that comes with chronic illness. It's time to change that, columnist Marisa Zeppieri says.

Telitacicept, a B-cell-targeting therapy developed by RemeGen, outperformed a placebo at reducing the severity of systemic lupus erythematosus (SLE) in a Phase 3 clinical trial in China, the company ...

Columnist Marisa Zeppieri shares her advice on how she and her husband work together to make the most out of their marriage despite illness.

The U.S. Food and Drug Administration (FDA) has approved for commercial use new automated diagnostic tests for lupus and for ANCA-associated vasculitis, both of which use the HELIOS system.

For columnist Candace Semien, knowing when to fill your cup is crucial to self-care, particularly to avoid or ease a lupus flare.

Lupkynis has been approved in Japan to treat lupus nephritis, when given alongside the immunosuppressant mycophenolate mofetil.

Lupuzor (rigerimod, or IPP-201101) combined with standard therapy did not demonstrate a statistically significant response rate in systemic lupus erythematosus (SLE) patients over standard care alone, ...

Stopping glucocorticoid therapy after achieving remission did not increase the risk of symptom flare-ups in SLE patients, data showed.